Skip to content

A multicenter randomized controlled trial for antiplatelet therapy for pediatric kawasaki disease with coronary artery aneurysm

A multicenter randomized controlled trial for antiplatelet therapy for pediatric kawasaki disease with coronary artery aneurysm

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019181
Enrollment
Unknown
Registered
2018-10-30
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki Dusease

Interventions

Group 2:Aspirin + clopidogrel

Sponsors

Children's Hospital Capital Institute of Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Children are diagnosed with KD and hospitalized for the first time; 2. Concomitant coronary artery aneurysm formation: within 4 weeks of the course of KD, echocardiography 1 to 2 times per week found the formation of medium-sized coronary artery aneurysms; 3. Patients are willing and able to abide by the study plan and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The KD patients with mild coronary artery aneurysm; 2. Patients are allergic to aspirin and clopidogrel; 3. Patients with peptic ulcer; 4. Patients with obvious abnormal liver function; 5. Patients with hemorrhagic diseases; 6. Combined with other vasculitis diseases.

Design outcomes

Primary

MeasureTime frame
echocardiogram;

Countries

China

Contacts

Public ContactXiaohui Li

Capital Institute of Pediatrics

lxhmaggie@126.com+86 13641091775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026